Andrew Protheroe
Andrew Protheroe
Affiliazione sconosciuta
Email verificata su
Citata da
Citata da
DNA-repair defects and olaparib in metastatic prostate cancer
J Mateo, S Carreira, S Sandhu, S Miranda, H Mossop, R Perez-Lopez, ...
New England Journal of Medicine 373 (18), 1697-1708, 2015
Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE): survival results from an adaptive, multiarm, multistage …
ND James, MR Sydes, NW Clarke, MD Mason, DP Dearnaley, MR Spears, ...
The Lancet 387 (10024), 1163-1177, 2016
Abiraterone plus prednisone in metastatic, castration-sensitive prostate cancer
K Fizazi, NP Tran, L Fein, N Matsubara, A Rodriguez-Antolin, ...
New England Journal of Medicine 377 (4), 352-360, 2017
Abiraterone for prostate cancer not previously treated with hormone therapy
ND James, JS de Bono, MR Spears, NW Clarke, MD Mason, ...
New England Journal of Medicine 377 (4), 338-351, 2017
The safety and feasibility of extracorporeal high-intensity focused ultrasound (HIFU) for the treatment of liver and kidney tumours in a Western population
RO Illing, JE Kennedy, F Wu, GR Ter Haar, AS Protheroe, PJ Friend, ...
British journal of cancer 93 (8), 890, 2005
The type 1 insulin-like growth factor receptor pathway
MM Chitnis, JSP Yuen, AS Protheroe, M Pollak, VM Macaulay
Clinical cancer research 14 (20), 6364-6370, 2008
Everolimus versus sunitinib for patients with metastatic non-clear cell renal cell carcinoma (ASPEN): a multicentre, open-label, randomised phase 2 trial
AJ Armstrong, S Halabi, T Eisen, S Broderick, WM Stadler, RJ Jones, ...
The Lancet Oncology 17 (3), 378-388, 2016
Patterns of relapse in patients with clinical stage I testicular cancer managed with active surveillance
C Kollmannsberger, T Tandstad, PL Bedard, G Cohn-Cedermark, ...
Journal of Clinical Oncology 33 (1), 51-57, 2014
Type 1 insulin-like growth factor receptor translocates to the nucleus of human tumor cells
T Aleksic, MM Chitnis, OV Perestenko, S Gao, PH Thomas, GD Turner, ...
Cancer research 70 (16), 6412-6419, 2010
Activity and safety of ODM-201 in patients with progressive metastatic castration-resistant prostate cancer (ARADES): an open-label phase 1 dose-escalation and randomised phase …
K Fizazi, C Massard, P Bono, R Jones, V Kataja, N James, JA Garcia, ...
The lancet oncology 15 (9), 975-985, 2014
Reo-10: a phase 1 study of intravenous reovirus and docetaxel in patients with advanced cancer
C Comins, J Spicer, A Protheroe, V Roulstone, K Twigger, CL White, ...
Clinical Cancer Research, clincanres. 1233.2010, 2010
Celecoxib plus hormone therapy versus hormone therapy alone for hormone-sensitive prostate cancer: first results from the STAMPEDE multiarm, multistage, randomised controlled trial
ND James, MR Sydes, MD Mason, NW Clarke, J Anderson, DP Dearnaley, ...
The lancet oncology 13 (5), 549-558, 2012
Extracorporeal high intensity focused ultrasound for renal tumours: a 3‐year follow‐up
RW Ritchie, T Leslie, R Phillips, F Wu, R Illing, G Ter Haar, A Protheroe, ...
BJU international 106 (7), 1004-1009, 2010
Recurrent chromosomal gains and heterogeneous driver mutations characterise papillary renal cancer evolution
M Kovac, C Navas, S Horswell, M Salm, C Bardella, A Rowan, M Stares, ...
Nature communications 6, 6336, 2015
The VHL tumor suppressor inhibits expression of the IGF1R and its loss induces IGF1R upregulation in human clear cell renal carcinoma
JSP Yuen, ME Cockman, M Sullivan, A Protheroe, GDH Turner, ...
Oncogene 26 (45), 6499, 2007
Remission of inflammatory arthropathy in association with anti-CD20 therapy for non-Hodgkin's lymphoma
A Protheroe, JCW Edwards, A Simmons, K Maclennan, P Selby
Rheumatology 38 (11), 1150-1152, 1999
Patient-reported outcomes following abiraterone acetate plus prednisone added to androgen deprivation therapy in patients with newly diagnosed metastatic castration-naive …
KN Chi, A Protheroe, A Rodríguez-Antolín, G Facchini, H Suttman, ...
The Lancet Oncology, 2018
A phase I trial of ispinesib, a kinesin spindle protein inhibitor, with docetaxel in patients with advanced solid tumours
SP Blagden, LR Molife, A Seebaran, M Payne, AHM Reid, AS Protheroe, ...
British journal of cancer 98 (5), 894, 2008
Cediranib monotherapy in patients with advanced renal cell carcinoma: results of a randomised phase II study
P Mulders, R Hawkins, P Nathan, I de Jong, S Osanto, E Porfiri, ...
European Journal of Cancer 48 (4), 527-537, 2012
Interleukin-7 deficiency in rheumatoid arthritis: consequences for therapy-induced lymphopenia
F Ponchel, RJ Verburg, SJ Bingham, AK Brown, J Moore, A Protheroe, ...
Arthritis Res Ther 7 (1), R80, 2004
Il sistema al momento non può eseguire l'operazione. Riprova più tardi.
Articoli 1–20